Roche 's R&D efforts focus on the next generation of diagnostic tools using smart software and connected data systems to spot serious health conditions before they can worsen.
Public source
Publisher name
Public post
Our R&D efforts at Roche focus on the next generation of diagnostic tools, using smart software and connected data systems to spot serious health conditions before they…
Company
Roche
- Industry
- Biotechnology Research
- Location
- Switzerland 🇨🇭, CH
- Company size
- 10,001+ employees
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation
See moreLatest activity
Latest activity from Roche
54 signals
Presence & Recognition
Roche celebrated its 30th anniversary in Slovenia.
Presence & Recognition
Roche participated in the RhK2026 conference in Leipzig on September 10, 2026, discussing the treatment of remission in SLE and lupus nephritis from both rheumatological and nephrological perspectives.
People
Roche is hiring a Medical Director for the Yale New Haven Hospital Multi-Specialty Long COVID Care Center to lead clinical care, clinic operations, and quality initiatives.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Genentech
Genentech and Roche are redefining how treatments are developed and delivered to build a seamless continuum of care and transform patient outcomes globally.
Research & Knowledge
Roche Danmark
Roche Danmark published an analysis and report on the Danish healthcare system, including a paper and a plan for implementing a national diagnostic strategy.
Research & Knowledge
Thermo Fisher Scientific
Thermo Fisher Scientific researcher Dr. Jennifer Van Eyk describes a goal for the field of proteomics to move beyond single-point diagnosis monitoring to understand response to therapy, shifts in health, and risk over time.
Research & Knowledge
Tecan
Tecan's team conducted its largest-ever drug screen testing 283 antioxidant compounds for RCBTB1-associated retinopathy using iPSC-derived retinal cells, multimodal imaging, and luminescence analysis.
Research & Knowledge
AMYRA Biotech AG